5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | NEUTRAL | BUY | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 26.09▼ | 26.31▼ | 26.31▼ | 22.53▲ | N/A |
MA10 | 26.50▼ | 25.99▼ | 25.74▼ | N/A | N/A |
MA20 | 26.17▼ | 24.70▲ | 24.07▲ | N/A | N/A |
MA50 | 24.41▲ | 21.47▲ | N/A | N/A | N/A |
MA100 | 21.81▲ | N/A | N/A | N/A | N/A |
MA200 | N/A | N/A | N/A | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.265▼ | -0.064▼ | 0.056▲ | N/A | N/A |
RSI | 47.159▼ | 57.447▲ | 59.929▲ | N/A | N/A |
STOCH | 28.914 | 73.779 | 74.251 | N/A | N/A |
WILL %R | -100.000▼ | -58.140 | -40.486 | N/A | N/A |
CCI | -147.652▼ | -20.580 | 14.732 | N/A | N/A |
▲ GAP | $TVRD Open Gap Up %2 | Set Alert |
Monday, April 28, 2025 11:49 AM
Investors in Cara Therapeutics (NASDAQ:CARA), Inc. CARA need to pay close attention to the stock based on moves in the options... Kodiak Sciences (NASDAQ:KOD) Inc. KOD announced that it has ...
|
Thursday, April 17, 2025 09:14 AM
There are no SEC filings that match your filter(s), please update your selections to return more records. Nasdaq provides company’s SEC filings, which are financial statements and reports filed ...
|
Wednesday, April 16, 2025 03:21 PM
Tvardi Therapeutics, Inc. (Nasdaq: TVRD), a clinical-stage biopharmaceutical company developing novel STAT3 inhibitors for fibrosis-driven diseases, visits the Nasdaq MarketSite in Times Square.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 24.85 | 27.75 | 24.85 | 25.45 | 44,100 |
30/04/25 | 23.00 | 26.13 | 21.55 | 24.94 | 39,900 |
29/04/25 | 20.45 | 23.52 | 19.99 | 22.38 | 54,148 |
28/04/25 | 19.19 | 22.3846 | 17.85 | 21.02 | 69,167 |
25/04/25 | 17.50 | 18.85 | 17.02 | 18.85 | 13,381 |
24/04/25 | 16.61 | 18.85 | 16.61 | 17.80 | 25,331 |
23/04/25 | 19.00 | 20.04 | 18.48 | 18.48 | 20,622 |
22/04/25 | 17.50 | 20.99 | 17.4875 | 19.49 | 41,141 |
21/04/25 | 16.10 | 18.75 | 15.80 | 17.47 | 10,300 |
|
|
||||
|
|
||||
|
|